|
|
|
|
UNITED STATES |
|
|
SECURITIES AND EXCHANGE COMMISSION |
|
|
Washington, D.C. 20549 |
|
|
|
|
SCHEDULE 13G
Under
the Securities Exchange Act of 1934
SUCAMPO PHARMACEUTICALS, INC.
(Name of Issuer)
Class A Common Stock
(Title of Class of Securities)
864909106
(CUSIP Number)
December 31, 2007
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
o |
Rule 13d-1(b) |
o |
Rule 13d-1(c) |
x |
Rule 13d-1(d) |
Check the following box if a fee is being paid with this statement. o
CUSIP No. 864909106 |
|||||
|
|||||
|
1. |
Names of Reporting Person
I.R.S Identification No. of Avbove Person 52-2242847 |
|||
|
|||||
|
2. |
Check the Appropriate Box if a Member of a Group (See Instructions) |
|||
|
|
(a) |
o |
||
|
|
(b) |
o |
||
|
|||||
|
3. |
SEC Use Only |
|||
|
|||||
|
4. |
Citizenship or Place of
Organization |
|||
|
|
|
|||
Number of |
5. |
Sole Voting Power |
|||
|
|||||
6. |
Shared Voting Power |
||||
|
|||||
7. |
Sole Dispositive Power |
||||
|
|||||
8. |
Shared Dispositive Power |
||||
|
|||||
|
9. |
Aggregate Amount
Beneficially Owned by Each Reporting Person |
|||
|
|||||
|
10. |
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) o |
|||
|
|||||
|
11. |
Percent of Class
Represented by Amount in Row (9) |
|||
|
|||||
|
12. |
Type of Reporting Person
(See Instructions) |
|||
(1) Includes 26,191,050 shares of Class B Common Stock of the issuer. Each share of Class B Common Stock is convertible at any time into one share of Class A Common Stock without further consideration.
2
Item 1. |
||
|
(a) |
Name of Issuer |
|
(b) |
Address of Issuers
Principal Executive Offices Suite 300 Bethesda, Maryland 20814 |
|
||
Item 2. |
||
|
(a) |
Name of Person Filing |
|
(b) |
Address of Principal
Business Office or, if none, Residence Suite 700 Bethesda, MD 20814-8410 |
|
(c) |
Citizenship |
|
(d) |
Title of Class of
Securities |
|
(e) |
CUSIP Number |
|
3
Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
|
Not Applicable |
Item 4. |
Ownership |
||
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. |
|||
|
(a) |
Amount beneficially owned: 27,500,802(2) |
|
|
(b) |
Percent of class: 65.9% |
|
|
(c) |
Number of shares as to which the person has: |
|
|
|
(i) |
Sole power to vote or to direct the vote 27,500,802(2) |
|
|
(ii) |
Shared power to vote or to direct the vote 0 |
|
|
(iii) |
Sole power to dispose or to direct the disposition of 27,500,802(2) |
|
|
(iv) |
Shared power to dispose or to direct the disposition of 0 |
|
|||
Item 5. |
Ownership of Five Percent or Less of a Class |
||
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
Not Applicable |
|||
|
|||
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person |
||
Not Applicable |
|||
|
|||
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person |
||
Not Applicable |
(2) See footnote 1 on the cover page to this schedule.
4
Item 8. |
Identification and Classification of Members of the Group |
Not Applicable |
|
|
|
Item 9. |
Notice of Dissolution of Group |
Not Applicable |
|
|
|
Item 10. |
Certification |
Not Applicable |
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
||
|
|
||
Dated: February 14, 2008 |
S&R Technology Holdings, LLC |
||
|
|
||
By: |
/s/ Sachiko Kuno |
||
Name: |
Sachiko Kuno |
||
|
|
||
|
|
||
5